CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- Open-market buys, last 90 days
- $319,000
- in 1 filing
- Open-market sales, last 90 days
- $128,281
- in 3 filings
Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-05 | Quinn William P. President, CEO and CFO | Purchase | +125 | $4.61 | $576 | 2,313 |
| 2025-12-05 | Nemec Sarah Senior VP, Finance and PAO | Purchase | +125 | $4.61 | $576 | 1,415 |
| 2025-10-22 | Nemec Sarah Senior VP, Finance and PAO | Grant or award | +23,000 | 23,943 | ||
| 2025-10-22 | Yonehiro Grant Chief Operating Officer | Grant or award | +30,000 | 38,918 | ||
| 2025-10-22 | Quinn William P. President, CEO and CFO | Grant or award | +40,000 | 42,188 | ||
| 2025-06-06 | Nemec Sarah Senior VP, Finance and PAO | Purchase | +125 | $5.49 | $687 | 943 |
| 2025-06-06 | Quinn William P. President, CEO and CFO | Purchase | +125 | $5.49 | $687 | 2,188 |
| 2025-05-27 | Dupont Jakob Director | Grant or award · Stock Option (Right to Buy) | +1,100 | 1,100 | ||
| 2025-05-27 | Berner Laura Director | Grant or award · Stock Option (Right to Buy) | +1,100 | 1,100 | ||
| 2025-05-27 | ONETTO NICOLE Director | Grant or award · Stock Option (Right to Buy) | +1,100 | 1,100 | ||
| 2025-05-27 | LAPORTE KATHLEEN Director | Grant or award · Stock Option (Right to Buy) | +1,100 | 1,100 | ||
| 2025-05-27 | O'CALLAGHAN BRIAN Director | Grant or award · Stock Option (Right to Buy) | +1,100 | 1,100 | ||
| 2025-05-01 | Dupont Jakob Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2025-05-01 | Yonehiro Grant Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2025-05-01 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Stock Option (Right to Buy) | +226,000 | 226,000 | ||
| 2025-05-01 | Quinn William P. President, CEO and CFO | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2024-12-16 | Nemec Sarah Senior VP, Finance and PAO | Purchase | +2,500 | $0.50 | $1K | 16,633 |
| 2024-12-16 | Quinn William P. President, CEO and CFO | Purchase | +2,500 | $0.50 | $1K | 41,272 |
| 2024-09-03 | Dupont Jakob Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-09-03 | Dupont Jakob Director | Grant or award · Stock Option (Right to Buy) | +16,984 | 16,984 |
Page 8 of 17 · 337 trades